Intraoperative transfusion practices in Europe by Meier, J et al.
Intraoperative transfusion practices in Europe
J. Meier1,*, D. Filipescu2, S. Kozek-Langenecker3, J. Llau Pitarch4, S. Mallett5,
P. Martus6 and I. Matot7 and the ETPOS collaborators
1Clinic of Anesthesiology and Intensive Care Medicine, Faculty of Medicine of the Kepler University Linz, Linz,
Austria, 2Emergency Institute of Cardiovascular Disease, University Bucharest, Bucharest, Romania, 3Department
of Anesthesiology and Intensive Care Medicine, EKH Evangelic Hospital Vienna, Vienna, Austria, 4Department of
Anesthesiology and Intensive Care Medicine, Hospital Clínico Universitario de Valencia, Valencia, Spain,
5Department of Anesthesiology, Royal Free Hospital Hampstead NHS Trust, London, UK, 6Clinical Epidemiology,
Eberhard Karls University Tübingen, Tübingen, Germany, and 7Department of Anesthesiology & Intensive Care
Medicine & Pain, Tel Aviv Medical Centre, Tel Aviv, Israel
*Corresponding author. E-mail: jens.meier@gmail.com
Abstract
Background: Transfusion of allogeneic blood inﬂuences outcome after surgery. Despite widespread availability of transfusion
guidelines, transfusion practices might vary among physicians, departments, hospitals and countries. Our aim was to
determine the amount of packed red blood cells (pRBC) and blood products transfused intraoperatively, and to describe factors
determining transfusion throughout Europe.
Methods: Wedid a prospective observational cohort study enrolling 5803 patients in 126 European centres that received at least
one pRBC unit intraoperatively, during a continuous three month period in 2013.
Results: The overall intraoperative transfusion ratewas 1.8%; 59% of transfusionswere at least partially initiated as a result of a
physiological transfusion trigger- mostly because of hypotension (55.4%) and/or tachycardia (30.7%). Haemoglobin (Hb)- based
transfusion trigger alone initiated only 8.5% of transfusions. The Hb concentration [mean ()] just before transfusion was 8.1
(1.7) g dl−1 and increased to 9.8 (1.8) g dl−1 after transfusion. Themean number of intraoperatively transfused pRBCunitswas 2.5
(2.7) units (median 2).
Conclusions: Although European Society of Anaesthesiology transfusion guidelines are moderately implemented in Europe
with respect to Hb threshold for transfusion (7–9 g dl−1), there is still an urgent need for further educational efforts that focus on
the number of pRBC units to be transfused at this threshold.
Clinical trial registration: NCT 01604083.
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It is now considered good clinical practice to use a restrictive
transfusion regimen into clinical pathways in order to minimize
unnecessary use of allogeneic blood.1–3 This is consistent with
the current ‘patient blood management’ (PBM) paradigm, a
multidisciplinary, multimodal approach to best transfusion
practice.4–6 However, despite the general belief that PBM is use-
ful and improves outcome, implementation of all measures of
this package is difﬁcult, time consuming, and as a consequence
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is seldom performed completely.6–8 The degree to which guide-
lines have resulted in consensus in community transfusion
practice is unknown. Previous European studies evaluating
transfusion practiceswere limited in size and pertained to a sin-
gle country.9–11 Little is known about the intraoperative transfu-
sion triggers used and the transfusion strategy applied in
clinical practice across Europe.12 Therefore, the primary goal
of our study was to assess transfusion triggers and existing
transfusion practices and the use of packed red blood cell
(pRBC), fresh frozen plasma (FFP), and platelet transfusions in
a large sample of European centres.
Methods
Study design and participants
The ETPOS (European Transfusion Practice and Outcome Study)
protocol was designed as a prospective, observational, multicen-
tre European study. Centres volunteered to participate in the
study via the homepage of the European Society of Anaesthesi-
ology (ESA). Each centre had to contact the local ethics committee
and/or the relevant regulatory approving body in order to deter-
mine whether obtaining informed consent was necessary or
could be waived. If informed consent was required, only patients
that agreed to participate and signed a consent form were in-
cluded in the study. The inclusion procedure stipulated post-
operative informed consent for the usage of data obtained. If a
patient died before consent could be obtained, data were not
used. No centre started without all mandatory local ethical or
regulatory requirements being fulﬁlled.
All patients undergoing an elective noncardiac surgical pro-
cedure at each of the participating hospitals were screened for in-
clusion. Only patients that received intraoperatively at least one
pRBC unit during the study period (April 1st – December 31st,
2013) were included in the analysis. Data acquisition time was
three consecutive months for each centre. There were no further
speciﬁc inclusion criteria. The only exclusion criteria was age
<18 yr and cardiothoracic, emergency, or trauma surgery.
Pre-study survey
Each centre participating in the study was asked to ﬁll in a pre-
study survey. The main characteristics requested were the size of
the hospital (beds), specialities provided, and several aspects of
the transfusion regimen and blood management of the hospital.
Data collection
Data were collected on patient characteristics (sex, age, body
weight and height); ASA physical status; duration of anaesthesia;
type of surgery; usage of point of care coagulation monitoring;
laboratory values (Hb, INR, aPTT, platelets, ﬁbrinogen) at begin-
ning of surgery, just before transfusion of ﬁrst pRBC, and at
the end of surgery; reason for the transfusion of the ﬁrst pRBC
(Hb threshold, physiological transfusion triggers, transfusion
relevant comorbidities, massive acute bleeding); ﬂuid volume,
blood products, and procoagulant drugs administered until end
of surgery [pRBC, crystalloids, colloids, cell saver, FFP, platelet
concentrates, tranexamic acid, prothrombin complex concen-
trate (PCC), ﬁbrinogen, recombinant factor VIIa, cryopreciptate,
factor XIII]; estimated volume loss until end of surgery (blood
loss, urine output, other ﬂuids). An overview of the protocol is
provided in the appendix.
Primary endpoints were: (i) amount of pRBC and blood pro-
ducts and coagulation factors transfused, and (ii) factors deter-
mining transfusion of pRBC and blood products in different
regions of Europe.
Data acquisition and quality management
The data collection and management was done using the Open-
Clinica open source software, version 3.2. (Copyright© OpenClini-
ca LLC and collaborators, Waltham, MA, USA, www.OpenClinica.
com). Data were collected on paper by the physician providing
anaesthesia and recorded afterwards into the study database.
The login names and passwords were provided for registration
of patients, monitoring of recruiting progress, query manage-
ment, and source data veriﬁcation and an internal communica-
tion platform. Automatic data entry plausibility checks and
mandatory data items enforced high data quality. Furthermore
three different data cleaning runs were donewith several checks
ensuring high data quality.
Statistical analysis
Our aimwas to recruit asmany participating hospitals as possible
and to recruit every eligible patient receiving at least one pRBC
during surgery in those hospitals.We anticipated that aminimum
sample size of 10 000 patients would enable a precise estimate
of current transfusion triggers throughout Europe. Therefore we
aimed at 100 participating centres providing 100 patients each.
This sample size was also expected to provide sufﬁcient data to
be able to describe transfusion practices in different settings.
We used SPSS (version 21.0) for data analysis. Categorical vari-
ables are presented as number (%) and continuous variables as
mean () when normally distributed or median (IQR) when not.
This study is registered with ClinicalTrials.gov, number
NCT01604083.
Role of the funding source
The study was funded by a grant of the ESA Clinical Trial Net-
work. An independent steering committee was responsible for
study design, conduct, and data analysis. Members of the steer-
ing committee had full access to the study data and were solely
responsible for interpretation of the data, drafting and critical re-
vision of the report, and the decision to submit for publication.
Results
One hundred and twenty six hospitals of 30 European countries
participated in the study (overview is given in the appendix).
Pre-study survey
An overview of the parameters included in the pre-study survey
is given in Table 1.
Of the 126 centres with valid patients all 126 ﬁlled in the pre-
study survey (with one being incomplete). Approximately a third
of the centres (n=40) had less than 500 beds, 50 (40%) had between
500 and 1000 beds and 36 (28%) had more than 1000 beds.
Editor’s key points
• There is marked variation in blood transfusion practices.
• Most transfusions given intraoperatively are for hypoten-
sion or other indicators of tissue hypoperfusion.
• A transfusion threshold or trigger is less relevant in the in-
traoperative setting.
• Single unit red cell transfusions should be usedmore often.
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Themedian number of operating theatres in each hospital was 18
(10–20). Most centres reported a higher number of board certiﬁed
anaesthetists than anaesthetists in training. All relevant
specialities were covered by the participating hospitals. A negli-
gible amount of centres reported that they used measures to
pre-optimize their patients before surgery with either iron or
erythropoietin. Conventional coagulation tests were used by
more than 90% of the centres, whereas point of care monitoring
systems were implemented only by 14–30% of the centres de-
pending on the speciﬁc monitoring device. Fifty seven percent
of the hospitals use transfusion protocols, the majority of them
based on conventional (laboratory) coagulation tests. Sixty
three percent of the hospitals reported having a restrictive trans-
fusion protocol implemented for pRBC, 63% for FFP, 82% for
platelets and 80% for coagulation factors.
General data
In total 373 732 patients were screened (Table 2). The ﬁrst patient
was enrolled on April 1st, 2013, and the last patient December
31st, 2013. Data were obtained for 5929 patients for whom in-
formed consent was obtained or waived, of which 126 were ex-
cluded, having been identiﬁed as duplicates or having missing
transfusion data, leaving 5803 subjects for analysis (Table 1).
A mean number of 45 (range: 1–165) patients were included per
Table 2 Patient and perioperative characteristics (n=5803)
Variable
Age (yr) 63.7 (16.1)
Male 49%
BMI 26.2 (5.3)
ASA physical status
I 5.5%
II 31.0%
III 45.9%
IV 16.5%
V 1.1%
Type of surgery
Orthopaedic 21.6%
Lower gastrointestinal 12.4%
Vascular 9.9%
Upper gastrointestinal 9.3%
Hepatobiliary 7.9%
Gynaecological 7.5%
Urological 6.7%
Others 24.7%
Cancer Surgery 36.8%
Duration of Surgery (h) 4.1 (2.7)
Point of Care Device used 15.6%
Table 1 Prestudy survey of participating hospitals (n=126):
casemix, haemostasis and transfusion practices. Values are
given as median (IQR) or %. INR, international normalized ratio,
apTT, partial thromboplastin time, ACT, activated clotting time,
TEG, thrombelastography, TEM, thrombelastometry; percentage
values do not necessarily add up to 100% as multiple selections
were possible
Hospital characteristics
Beds
<500 40
501–999 50
>1000 36
no. of operating theatres 18 (10–26)
no. of surgical procedures per yr
(estimation)
15 000 (7050–25 000)
no. of board certiﬁed anaesthetists 26 (13–47)
no. of anaesthetists in training 17 (7–30)
Hospital specialties
Orthopaedics 88%
Visceral surgery 89%
Urology 86%
Gynaecology 90%
Vascular Surgery 79%
Trauma 80%
Ear Nose Throat 84%
Thoracic Surgery 63%
Cardiac Surgery 51%
Neurosurgery 67%
Hepato – biliary surgery 83%
Dental surgery 64%
Plastics 74%
Ophthalmology 73%
Estimated % of patients prepared with. . .
Oral iron 1 (0–5)
i.v. iron 1 (0–2)
Erythropoietin 0 (0–1)
Perioperative haemostasis monitoring
- conventional monitoring 90%
- INR 90%
- apTT 85%
- ﬁbrinogen 80%
- platelets 90%
- ACT 24%
Point of care monitoring
- INR/apTT 18%
- TEG 16%
- ROTEM 30%
- Multiplate, Verify Now, Platelet
Mapping
14%
Massive transfusion
% of hospitals with transfusion
protocols
57%
- based on packages 21%
- based on ratios 27%
- based on conventional coagulation
tests
50%
- based on POC testing 31%
- based on experience 37%
Transfusion regimen
- for pRBCs liberal: 30%
restrictive: 63%
- for FFPs liberal: 31%
restrictive: 63%
Continued
Table 1 Continued
- for coagulation factors liberal: 12%
restrictive: 82%
- for platelets liberal: 13%
restrictive: 80%
Transfusion practice
- leukocyte reduced pRBCs used 54%
- non-leukocyte reduced pRBCs used 46%
- cryoprecitates used 48%
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hospital and 193 (range: 5–783) per country. The study included
almost equal numbers of females and males, with a mean age
of 64 (13; range 18–100) yr, approximately half of whom were
categorized into ASA class III. Orthopaedic and lower gastrointes-
tinal surgery were performed most frequently and around third
of the operations were for cancer. A point of care device for mon-
itoring of blood coagulation was used in 15.6% of patients.
Course of transfusion
Themean reported blood losswas 1392 (2040)ml (Table 3). In gen-
eral, 82% of the patientswere anaemic as deﬁned by theWHO cri-
teria (male<13 g dl−1, female<12 g dl−1) preoperatively with
baseline (pre-surgery) Hb concentration of 10.6 (2.4) g dl−1. Before
transfusion of the ﬁrst pRBC, measured Hb concentration was 8.1
(1.7) g dl−1 and increased to 9.8 (1.8) g dl−1 at the end of surgery.
Themean number of transfused pRBCwas 2.5 (2.7) units (Median
2 [IQR 2-2]). One third of patients received 1 pRBC and 41% of pa-
tients received 2 pRBC. There was no correlation between the Hb
concentration before transfusion or at the end of surgery and the
amount of pRBC units administered (correlation coefﬁcient −0.1
and −0.2, respectively). Conventional coagulation tests varied
only slightly over time.
Thirty one percent of patients received FFP and 7% of patients
received platelets. In patients receiving FFP themean amount ad-
ministered was 4.5 (5.9) units and with platelets the mean
amount was 3.0 (4.1) units. An overview for all other ﬂuids admi-
nistered is given in Table 4.
Reason for transfusion
An overview of the rationales for transfusion is given in Table 5.
The most prevalent basis for transfusion of the ﬁrst pRBC
was the occurrence of a physiological transfusion trigger (14.3%).
The second most important reason was the combination of a
physiological transfusion trigger with a suspected or known co-
morbidity (12.5%). In total 58.9% were transfused at least in part
as a result of a physiological transfusion trigger. Only 8.5% of
transfusions have been administered solely because of an Hb-
based transfusion trigger. If an Hb based transfusion trigger
was used, the physician chose an Hb value of 8.1 (1.3) g dl−1. Not-
ably, most of the physiological transfusion triggers were not lac-
tic acidosis (7.3%) or a decline of ScvO2 (1.3%) but hypotension
(55.4%) and tachycardia (30.7%). Themost important comorbidity
resulting in transfusion was cardiovascular (35.7%), whereas all
other comorbidities were uncommon (<9%). Regression analysis
found that the amount of pRBC administered decreased with
age of patients, and was also not affected by the type of surgery.
Table 4 Blood product volume administered. pRBC, packed red
blood cells, FFP, fresh frozen plasma, PCC, prothrombin complex
concentrates
Blood product Patients Amount administered
pRBC –intraoperative 100% 2.5 (2.7) units
Crystalloids 99% 2434 (1784) ml
Colloids 65% 907 (711) ml
Cell Saver blood 6% 1116 (1388) ml
FFP 31% 4.5 (5.9) units
Platelet concentrate 7% 3.0 (4.1) units
Tranexamic acid 13% 1.4 (1.0) g
PCC 2% 1846 (1476) I.U.
Fibrinogen concentrate 5% 3.2 (2.4) g
Cryoprecipitate 1% 7.2 (5.8) units
Factor XIII <1% 2119 (1338) I.U.
pRBC –postoperative 56% 3.7 (4.1) units
Table 3 Transfusion data (n=5803). Values are reported as mean
(). Hb, haemoglobin. INR, international normalized ratio,
aPTT, activated partial thromboplastin time
Variable No. Value
Estimated blood loss (ml) 1392 (2040)
Begin of surgery
Hb (g dl−1) 5674 10.6 (2.4)
INR (%) 4500 1.2 (0.5)
aPTT (sec) 4004 33 (17)
Platelets (n microl−1) 5180 265 (132)
Fibrinogen (mg dl−1) 1838 400 (177)
Just before transfusion
Hb (g dl−1) 3977 8.1 (1.7)
INR (%) 630 1.4 (0.9)
aPTT (s) 570 43 (38)
Platelets (n microl−1) 844 209 (127)
Fibrinogen (mg dl−1) 481 297 (174)
End of surgery
Hb (g dl−1) 4352 9.8 (1.8)
INR (%) 1985 1.4 (4.7)
aPTT (s) 1944 38 (27)
Platelets (n microl−1) 2639 202 (119)
Fibrinogen (mg dl−1) 1402 307 (163)
Table 5Reasons for transfusion ofﬁrst packed red blood cell unit.
Hb, haemoglobin; SvO2 , mixed venous oxygen saturation, ScvO2,
central venous oxygen saturation
Hb alone 8.5%
Hb & physiological trigger 8.2%
Hb & comorbidity 8.7%
Hb & physiological trigger & comorbidity 11.4%
physiological trigger irrespective of Hb 14.3%
physiological trigger & comorbidity 12.5%
physiological trigger & blood loss 7.1%
physiological trigger & blood loss & comorbidity 5.4%
Comorbidity alone 5.3%
Hb & physiological trigger & blood loss & comorbidity 4.6%
other combinations 14%
Physiological transfusion triggers
Hypotension 55.4%
Tachycardia 30.7%
Acidosis 7.8%
Lactate 7.3%
Arrhythmia 5.1%
ECG 2.7%
ScvO2 or SvO2 3.4%
Other 10.2%
Comorbidity
Cardiovascular 35.7%
Renal 8.1%
Pulmonary 7.7%
Haematological 6.9%
Gastrointestinal 6.4%
Others 8.6%
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Furthermore, the country had aminimal role, with only two pair-
wise comparisons between countries being statistically signiﬁ-
cant although of arguable clinical relevance. The size of the
hospital and academic degree did not inﬂuence transfusion prac-
tice. Differences between single hospitals havewere not analysed
because of insufﬁcient sample sizes.
Hospitals with different transfusion strategies
Sixty three percent of all hospitals stated to have a restrictive
transfusion strategy in the pre-study survey, in contrast to the
37% with a liberal transfusion strategy. Hospitals with a restrict-
ive strategy treated 64% of patients. Indeed, hospitals claiming a
more restrictive strategy tended to transfuse at lower Hb concen-
trations and accept a lower Hb value post-transfusion. As a con-
sequence, in these hospitals signiﬁcantly less transfusions were
needed despite comparable blood loss in both groups. Further-
more less postoperative transfusions and less substitution of
FFP coagulation factors were necessary in the restrictive group
(Table 6).
Discussion
It has been previously demonstrated that transfusion practice
differs between different physicians, centres, and countries.9–11 13
For elective surgery, the hospital might therefore be the most im-
portant determinant of the number of administered transfusions,
with some adopting programmes to reduce transfusions, while
others negating the importance of PBMmeasures on perioperative
outcome.14 There is growing evidence that a restrictive transfusion
strategy canbeused inmost clinical settings,withpublishedguide-
lines focusing on PBM of the surgical patient.2 4
We found that blood transfusions are rarely used inmost sur-
gical procedures, with only 1.8% transfused intraoperatively with
pRBC. The intraoperative transfusion rate will depend, among
other things, on a hospital’s surgical casemix and transfusion
practices. In the current study the pre-transfusion Hb concentra-
tion averaged 8.1 (1.7) g dl−1. A Hb trigger of 7–9 g dl−1 has been re-
commended during active bleeding by ESA guidelines.15 Thus,
the old commonly used Hb threshold of 10 g dl−1 is no longer
the ‘magic number’ for transfusion, with European centres now
practicing according to current transfusion guidelines, at least
in the intraoperative period. The post-transfusion Hb, though,
was unnecessarily high (9.8 (1.8) g dl−1), suggesting that the deci-
sion to transfuse led to more than 1 pRBC unit at a time. Some
hospitals that claimed to have a restrictive transfusion strategy
transfused at rather high Hb concentrations. There is thus still
a need for further educational efforts that focus restrictive trans-
fusion approach and on the number of pRBC units to be trans-
fused at this threshold.
The primary rationale for pRBC transfusion has not been pre-
viously studied in depth. The current study found that the most
frequent triggers for pRBC administration are physiological para-
meters; 8.5% of transfusions were initiated based only on Hb
value. It is worth noticing that if a physiological transfusion trig-
ger had been used, the Hb value chosen for transfusion was 8.1
(1.3) g dl−1, a level very close to the Hb value just before transfu-
sion of the ﬁrst pRBC in all patients. This fact suggests that
in reality many clinicians use the Hb value as an adjunctive
(‘hidden’) transfusion trigger, even if physiological triggers are
believed to be the primary trigger. The physiological parameters
used to trigger transfusion in themajority of patients were hypo-
tension and tachycardia. The triggerswith the highest discrimin-
atory power to manifest tissue hypoxia (e.g. lactate and mixed
venous central or central venous saturation) played only a sec-
ondary role. Thismay reﬂect the tendency ofmany anaesthetists
to use the most easily accessible parameters (heart rate and
bp) rather than those that require additional invasive catheters.
It may also reﬂect the emphasis anaesthetists give to main-
tenance of haemodynamic stability, with less focus on tissue
oxygenation.
Preoperative anaemia is one of the most important determi-
nants of intraoperative transfusion, and therefore it had been re-
commended that elective surgery of anaemic patients should be
postponed to enable adequate patient preparation.16 Further-
more, it has been demonstrated, that evenmild ormoderate pre-
operative anaemia is associated with signiﬁcant morbidity and
mortality.17 Therefore, PBM guidelines state that preoperative op-
timization of Hb is recommended to avoid unnecessary transfu-
sions.1 2 4 6 18 19 The present study found that the majority of
centres have not adopted this recommendation. Only 1% of cen-
tres prepared their patients with oral/i.v. iron and/or erythropoi-
etin. As 82% of transfused patients in the current study were
anaemic at the beginning of the surgery, it may be hypothesized
that preoperative Hb optimization could have avoided transfu-
sion to a certain extent. Because of the small number of patients
that were pre-treated for their anaemia, we cannot determine
whether those patients were less likely to be transfused.
Previous studies suggest that often more than 1 unit of pRBC
are transfused once a decision to administer blood has been
made, in part because of blood allocation strategies.20 In our
study more than 40% of patients had two pRBC units transfused;
as less than 25% of patients received three or more units of pRBC
it can be speculated that because two pRBC units is often ordered
Table 6 Perioperative characteristics according to self-reported restrictive or liberal red cell transfusion strategy. pRBC, packed red blood
cells, FFP, fresh frozen plasma
Restrictive (n=3738) Liberal (n=2065) P value
Haemoglobin value (g dl−1)
Beginning of surgery 10.6 (2.5) 10.8 (2.4) 0.0004
Just before transfusion 8.0 (1.7) 8.4 (1.6) 0.0000
End of surgery 9.6 (1.7) 10.1 (1.8) 0.0000
Units administered
pRBC –intraoperative 2.4 (2.5) 2.7 (2.5) 0.0000
FFP 4.1 (5.3) 5.2 (6.7) 0.0003
Platelet concentrate 3.1 (4.4) 2.9 (3.7) 0.89
pRBC –postoperative 1.9 (3.4) 2.3 (3.9) 0.0008
Estimated blood loss 1382 (2060) ml 1408 (2006) ml 0.22
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initially, they were given as package. To overcome this problem
Australia initiated a campaign, known as the ‘one unit policy’
where Hb levels are measured after each pRBC administered to
determine the necessity for further transfusion. The results of
the present study suggest that a similar campaign should be
implemented across Europe.
In our study the mean estimated blood loss was 1392 (2040)
ml, reﬂecting a high variability in blood loss, whichwarrants cau-
tious interpretation of our data. Unlike in trauma, wheremassive
transfusion protocols have been developed and shown to im-
prove outcome,21 protocols for the administration of blood pro-
ducts in the actively bleeding patient in the operating room are
missing. Modern guidelines promote use of a point of care mon-
itoring and coagulation factor-based bleeding management.15
This was not the case in the present study. Almost half of the pa-
tients received FFP, platelet concentrates or coagulation factor
concentrates. FFP, despite several adverse effects and poor efﬁ-
cacy22 is still the most commonly used agent during intraopera-
tive bleeding, whereas in ﬁve percent and two percent of patients
ﬁbrinogen concentrate and PCC were used, respectively. Para-
meters of routine coagulation tests did not reveal coagulopathy
either preoperatively and at the end of surgery. However, as im-
mediate pre-transfusion coagulation tests were not documented
for participating patients, conclusion regarding the appropriate-
ness of the administration of FFP, platelets or coagulation factors
cannot be made.
Our study has some limitations. We recorded selected data
and might therefore miss some of the factors that might inﬂu-
ence transfusion habits. We did not collect data on those not
transfused intraoperatively, not in those transfused before or
after surgery. We did not ﬁnd clinically relevant differences be-
tween countries. As centres participating and procedures in-
cluded varied essentially from country to country, differences
in transfusion habits might be more centre-speciﬁc than coun-
try-speciﬁc.
Conclusion
Across Europe, the vast majority of elective surgical patients re-
ceiving one or more units of RBC intraoperatively are anaemic
at the commencement of surgery (Hb 10.6 g dl−1), and correction
of anaemia before surgery deserves further study. Although the
transfusion trigger (Hb 8.1 g dl−1) is probably appropriate intrao-
peratively, post-transfusion Hb values were uniformly high (Hb
9.8 g dl−1) suggesting opportunity to use a single unit transfusion
stratagem. Physiological transfusion triggers seem to be themost
important catalyst for transfusion intraoperatively. But the
physiological triggers mainly used (hypotension and tachycar-
dia) might have a low discriminative power for tissue hypoperfu-
sion and often occur at Hb values that are considered safe for
tissue oxygenation in most patients.
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